Algo version: 0.98b
Smith & Nephew plc is listed at the LSE Exchange
Smith & Nephew plc [SN.L]
LSE Sector: Industry:Medical Devices

Is Smith & Nephew plc stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Smith & Nephew plc pays dividends. Last time was Friday 8th of November 2024 where the investors holding the stock on Thursday 3rd of October 2024 were paid GBP10.926 per share. Over the last 66 times between 1993 and 2024, Smith & Nephew plc has paid GBP475.913 with an average of GBP7.21 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Smith & Nephew plc 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was GBP1 934.00, you would have made a loss of GBP-735.50 per share or -38.03%

Yes, the average daily trading liquidity for Smith & Nephew plc is GBP2.28 million. You should therefore be able to get in and out of your positions relatively fast.

Smith & Nephew plc has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.20, the company's ability to pay off the debt is normal. The company has a very low net profit margin of 4.74%, which is challenging.

We have calculated the inflation risk for Smith & Nephew plc to be low [0.5 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.